Investigational Site Number :0560003

Edegem B-2650

0 studies enrolling now · 3 studies all time

What they study most

Colorectal Cancer, Gastric Cancer, Hepatocellular Carcinoma, Non-relapsing Secondary Progressive Multiple Sclerosis, Non-squamous Non-small Cell Lung Cancer, Oesophageal Adenocarcinoma, Oesophageal Squamous Cell Carcinoma

Studies at this site

• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) — Completed
• Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA — Stopped early
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed